Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

The Impact of HLA Mismatch Direction on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in AML Patients

Wen-Chun Chen, MD, Jyh-Pyng Gau, Sr., MD, Liang-Tsai Hsiao, MD PhD, Chia-Jen Liu, MD, Yao-Chung LIU, MD, Hao-Yuan Wang, MD, Po-Shen Ko, MD, Jin-Hwang Liu, MD PhD, Tzeon-Jye Chiou, MD

Blood (2019) 134 (Supplement_1): 4608.

https://doi.org/10.1182/blood-2019-125179

Published: 2019

Journal Articles

An External Validation Study for Current Risk Scoring Models in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Chia-Jen Liu, MD, Hong Ying-Chung, MD, Chiu-Mei Yeh, MS, Chun-Kuang Tsai, MD, Liang-Tsai Hsiao, MD PhD, Hao-Yuan Wang, MD, Yao-Chung LIU, MD, Jyh-Pyng Gau, MD, Po-Shen Ko, MD, Jin-Hwang Liu, MD PhD, Po-Min Chen, MD

Blood (2019) 134 (Supplement_1): 3861.

https://doi.org/10.1182/blood-2019-129597

Published: 2019

Journal Articles

Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients

Romanos Sklavenitis-Pistofidis, Marzia Capelletti, Chia-Jen Liu, Mairead Reidy, Oksana Zavidij, Daisy Huynh, Patrick Henrick, Alexandra Savell, Kaitlen Reyes, Bradley Rivotto, Mark Bustoros, Adriana Perilla-Glen, Lorenzo Trippa, Jorge J. Castillo, Steven P. Treon, Irene M. Ghobrial

Blood (2018) 132 (24): 2608–2612.

https://doi.org/10.1182/blood-2018-07-863241

Published: 2018

Journal Articles

Single-Cell RNA Sequencing Reveals Compromised Immune Microenvironment in Precursor Stages of Multiple Myeloma

Blood (2018) 132 (Supplement 1): 2603.

https://doi.org/10.1182/blood-2018-99-114145

Published: 2018

Journal Articles

A Phase Ib/II Study of the Novel Anti-CXCR4 Antibody Ulocuplumab (BMS-936564) in Combination with Lenalidomide Plus Low-Dose Dexamethasone, or with Bortezomib Plus Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma

Irene M. Ghobrial, MD, Chia-Jen Liu, MD PhD, Raymond P. Perez, MD, Paul Richardson, Kenneth C. Anderson, MD, Jacob Laubach, MD, Patrick Henrick, BS, Alexandra Savell, BS, Kaitlen Reyes, NP, Kalvis Hornburg, BA, Stacey Chuma, BSN, Peter Sabbatini, Pamela S. Becker, MD

Blood (2018) 132 (Supplement 1): 3263.

https://doi.org/10.1182/blood-2018-99-117773

Published: 2018

Journal Articles

The Role of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Multiple Myeloma: Immunomodulator Maintenance Post Autologous Stem Cell Transplant (ASCT) Predicts Better Outcome

Blood (2018) 132 (Supplement 1): 749.

https://doi.org/10.1182/blood-2018-99-113059

Published: 2018

Journal Articles

Phase II Trial of the Combination of Ixazomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Blood (2018) 132 (Supplement 1): 804.

https://doi.org/10.1182/blood-2018-99-117871

Published: 2018

Journal Articles

Progression Risk-Based Classification of Asymptomatic Waldenström Macroglobulinemia

Blood (2018) 132 (Supplement 1): 150.

https://doi.org/10.1182/blood-2018-99-114324

Published: 2018

Journal Articles

Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Chia-jen Liu, MD, Irene M. Ghobrial, MD, Mark Bustoros, MD, Kaitlen Reyes, NP, Kalvis Hornburg, BA, Ashraf Z. Badros, MD, James J. Vredenburgh, MD, Adam Boruchov, MD, Jeffrey V Matous, MD, Aaron Caola, BS, Bradley Rivotto, BS, Alexandra Savell, BS, Patrick Henrick, BS, Claudia E. Paba-Prada, MD, Robert L. Schlossman, MD, Jacob Laubach, MD, Jacalyn Rosenblatt, MD, Andrew J Yee, MD, Omar Nadeem, MD, Rodrigo O. Maegawa, MD, Andrzej Jakubowiak, MD PhD, Saad Z. Usmani, MD, Manisha Bhutani, MD, Joseph Cappuccio, BS, Brianna Berrios, BS, Kimberly Noonan, NP, Oksana Zavidij, PhD, Tarek H Mouhieddine, MD, Cody J Boehner, Carl-Jannes Neuse, Karma Ziad Salem, MD, Mairead Reidy, PhD, Jihye Park, PhD, Michael Agius, PhD, Mahshid Rahmat, PhD, Salomon Manier, MD PhD, Divaya Bhutani, MD, Jeffrey A Zonder, MD, Nikhil Munshi, MD, Daniel Auclair, PhD, Kenneth Anderson, MD, Paul Richardson

Blood (2018) 132 (Supplement 1): 154.

https://doi.org/10.1182/blood-2018-154

Published: 2018

Journal Articles

A New Prognostic Scoring System to Predict Disease Progression and Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma

Chia-Jen Liu, MD PhD, Chia-Hsin Lin, MD, Ying-Chung Hong, MD, Ching-Fen Yang, MD, Huai-Che Yang, MD, Li-Yu Fay, MD, Chiu-Mei Yeh, MS, Jyh-Pyng Gau, MD, Yuan-Bin Yu, MD, Tzeon-Jye Chiou, MD, Jin-Hwang Liu, MD PhD, Yao-Chung Liu, MD, Chung-Jen Teng, MD

Blood (2017) 130 (Supplement 1): 2858.

https://doi.org/10.1182/blood.V130.Suppl_1.2858.2858

Published: 2017

Journal Articles

Next Generation Sequencing Identifies Smoldering Multiple Myeloma Patients with a High Risk of Disease Progression

Blood (2017) 130 (Supplement 1): 392.

https://doi.org/10.1182/blood.V130.Suppl_1.392.392

Published: 2017

Journal Articles

Cerebrovascular Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, Risk and Clinical Outcome

Yao-Chung LIU, MD, Ting-An Lin, MD, Po-Shen Ko, MD, Hao-Yuan Wang, MD, Sheng-Hsuan Chien, MD, Chia-Jen Liu, MD PhD, Tzeon-Jye Chiou, MD, Liang-Tsai Hsiao, MD, Jyh-Pyng Gau, MD, Jin-Hwang Liu, MD PhD

Blood (2017) 130 (Supplement 1): 4527.

https://doi.org/10.1182/blood.V130.Suppl_1.4527.4527

Published: 2017

Journal Articles

The European Group for Blood and Marrow Transplantation Risk Score Predicts Outcome of Elderly Patients with Allogeneic Stem Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome

Sheng-Hsuan Chien, MD, Yao-Chung LIU, MD, Chia-Jen Liu, PhD, Jin-Hwang Liu, MD PhD, Jyh-Pyng Gau, MD, Tzeon-Jye Chiou, MD

Blood (2017) 130 (Supplement 1): 2041.

https://doi.org/10.1182/blood.V130.Suppl_1.2041.2041

Published: 2017

Journal Articles

Impact of Bone Marrow Biopsy on Risk Stratification of Low-Risk IgG MGUS Patients

Blood (2017) 130 (Supplement 1): 5397.

https://doi.org/10.1182/blood.V130.Suppl_1.5397.5397

Published: 2017

Journal Articles

Peripheral Stem Cell Transplantation Versus Bone Marrow Transplantation in Severe Aplastic Anemia - a Cohort of 149 Patients from a Single Medical Center in Taiwan

Po-Shen Ko, MD, Yao-Chung LIU, MD, Chiu-Mei Yeh, MS, Hao-Yuan Wang, MD, Ying-Chung Hong, MD, Jyh-Pyng Gau, MD, Liang-Tsai Hsiao, MD PhD, Yuan-Bin Yu, MD, Tzeon-Jye Chiou, MD, Po-Min Chen, MD, Kuo-Wei Chen, MD, Jin-Hwang Liu, MD PhD, Chia-Jen Liu, PhD

Blood (2017) 130 (Supplement 1): 1189.

https://doi.org/10.1182/blood.V130.Suppl_1.1189.1189

Published: 2017

Journal Articles

Prognostic role of circulating exosomal miRNAs in multiple myeloma

Blood (2017) 129 (17): 2429–2436.

https://doi.org/10.1182/blood-2016-09-742296

Published: 2017

Includes: Supplemental data

Journal Articles

Invasive Mold Infections in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Sheng-Hsuan Chien, MD, Yao-Chung Liu, MD, Nai-Wen Fan, MD, Chia-Jen Liu, PhD, Tzeon-Jye Chiou, MD, Jyh-Pyng Gau, MD, Jin-Hwang Liu, MD PhD

Blood (2016) 128 (22): 3434.

https://doi.org/10.1182/blood.V128.22.3434.3434

Published: 2016

Journal Articles

Spontaneous Post-Transplant Air-Leak Syndrome in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Sheng-Hsuan Chien, MD, Yao-Chung Liu, MD, Nai-Wen Fan, MD, Chia-Jen Liu, PhD, Tzeon-Jye Chiou, MD, Cheng-Hwai Tzeng, MD, Jyh-Pyng Gau, MD, Jin-Hwang Liu, MD PhD

Blood (2016) 128 (22): 5780.

https://doi.org/10.1182/blood.V128.22.5780.5780

Published: 2016

Journal Articles

Mycobacterial Infections in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study in a High Endemic Area

Liu Yao-Chung, Chi-Jung Wu, Sheng-Hsuan Chien, MD, Nai-Wen Fan, MD, Ming-Hung Hu, MD, Jyh-Pyng Gau, MD, Chia-Jen Liu, PhD, Yuan-Bin Yu, MD, Liang-Tsai Hsiao, MD, Tzeon-Jye Chiou, MD, Jin-Hwang Liu, MD PhD

Blood (2016) 128 (22): 2202.

https://doi.org/10.1182/blood.V128.22.2202.2202

Published: 2016

Journal Articles

Acute Myeloid Leukemia with Erythroid Predominance: A Reassessment Using Criteria Revised in the 2016 World Health Organization Classification

Po-Shen Ko, Yao-Chung Liu, Chiu-Mei Yeh, Liang-Tsai Hsiao, MD, Cheng-Hwai Tzeng, MD, Jyh-Pyng Gau, MD, Yuan-Bin Yu, MD, Tzeon-Jye Chiou, MD, Chia-Jen Liu, PhD, Po-Min Chen, MD PhD, Jin-Hwang Liu, MD PhD

Blood (2016) 128 (22): 4014.

https://doi.org/10.1182/blood.V128.22.4014.4014

Published: 2016

NARROW

The Impact of HLA Mismatch Direction on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in AML Patients

An External Validation Study for Current Risk Scoring Models in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients

Single-Cell RNA Sequencing Reveals Compromised Immune Microenvironment in Precursor Stages of Multiple Myeloma

A Phase Ib/II Study of the Novel Anti-CXCR4 Antibody Ulocuplumab (BMS-936564) in Combination with Lenalidomide Plus Low-Dose Dexamethasone, or with Bortezomib Plus Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma

The Role of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Multiple Myeloma: Immunomodulator Maintenance Post Autologous Stem Cell Transplant (ASCT) Predicts Better Outcome

Phase II Trial of the Combination of Ixazomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Progression Risk-Based Classification of Asymptomatic Waldenström Macroglobulinemia

Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

A New Prognostic Scoring System to Predict Disease Progression and Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma

Next Generation Sequencing Identifies Smoldering Multiple Myeloma Patients with a High Risk of Disease Progression

Cerebrovascular Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, Risk and Clinical Outcome

The European Group for Blood and Marrow Transplantation Risk Score Predicts Outcome of Elderly Patients with Allogeneic Stem Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome

Impact of Bone Marrow Biopsy on Risk Stratification of Low-Risk IgG MGUS Patients

Peripheral Stem Cell Transplantation Versus Bone Marrow Transplantation in Severe Aplastic Anemia - a Cohort of 149 Patients from a Single Medical Center in Taiwan

Prognostic role of circulating exosomal miRNAs in multiple myeloma

Invasive Mold Infections in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Spontaneous Post-Transplant Air-Leak Syndrome in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Mycobacterial Infections in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study in a High Endemic Area

Acute Myeloid Leukemia with Erythroid Predominance: A Reassessment Using Criteria Revised in the 2016 World Health Organization Classification

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only